S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

Completed

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy for breast cancer may damage the genes of cells. This may lead to the development of secondary cancers. PURPOSE: Pilot study to evaluate the degree of gene damage following chemotherapy in women with stage II or stage III breast cancer involving four to nine axillary lymph nodes.

Key facts

Study ID
NCT00003095
Run by
SWOG Cancer Research Network
People needed
26
Starts
1997-11-01
Expected to finish
2001-02-01
Last updated by the study team
2015-10-26

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.